Real-world studies show effectiveness of mogamulizumab in routine practice

AviadoBio to receive up to £1.8 billion in potential payments

Biotech company moves forward with phase 2 trial for precision cancer surgery

Scottish Medicines Consortium recommends pembrolizumab

Largest real-world study demonstrates significant survival advantage

ISM001-055 shows promise in improving lung function among patients

Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid

Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe

New government scheme to offer routine opt-out blood tests